<DOC>
	<DOCNO>NCT01259648</DOCNO>
	<brief_summary>The primary objective determine whether , rapid sequence intubation etomidate , succinylcholine Sellick maneuver , administration remifentanil 2 different dosage ( 0.5 1.0 microgram per kg body weight ) , reduce potentially dangerous reactional tachycardia .</brief_summary>
	<brief_title>Study Evaluating Efficacy Safety Remifentanil Rapid Sequence Induction Fragile Subjects</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>Patients require rapid sequence intubation whatever reason . This include following : full stomach , obesity , diabetic gastroparesis , gastroesophageal reflux Patient able give inform consent , sign consent . Contraindication use drug use ( regardless patient group ) : history serious side effect , allergic reaction Morbid obesity ( Body Mass Index &gt; 40 ) Emergency situation unstable hemodynamics , stabilization impossible induction Inclusion another research project within past 3 month The patient insure beneficiary health insurance plan ( French center ) Patient guardianship kind Patient unable give inform consent Refusal sign consent form</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>remifentanil</keyword>
	<keyword>anesthesia induction</keyword>
	<keyword>reactional tachycardia</keyword>
</DOC>